Before, we told you to delete your data because 23andMe was about to be sold. Now, a buyer has been announced, and they’re ...

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million: Tarrytown, New York Wednesday, May 21, 2025, 13:00 Hrs [IST] Regeneron Pharmace ...

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...

This week a group of researchers, bioethicists, publishers and theologians are discussing the merits of human heritable genome editing.

A new report by FutureWise Research highlights a powerful trend in modern medicine: as awareness and innovation rise, hope ...